Patriot Scientific Corporation Announces Three Purchases of Moore Microprocessor Patent(TM) Portfolio Licenses

CARLSBAD, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Patriot Scientific Corporation (OTC Bulletin Board: PTSC.OB) announced today three new MMP(TM) Portfolio licensees less than three weeks after the USPTO announced its decision to affirm the validity of US'336, the most widely recognized patent in the MMP Portfolio. The new licensees include Harman International, TPV Technology, and Textron Inc., and will result in both upfront and future payments.

The agreements follow a string of successes in the reexamination of the MMP Portfolio(TM) patents by the USPTO and German Patent Court. In the past 9 months, the German Patent Court affirmed the validity of EP'730, and the USPTO has affirmed the validity of both US'584 and most recently US'336.

Despite the risk of willful infringement in cases where companies delay licensing decisions on the basis of reexams, companies have been awaiting the outcome of US'336 and are now reengaging in licensing discussions in light of the escalating royalty rate structure of the MMP Portfolio(TM) Licensing Program.

Harman Industries is a worldwide leader in the manufacture of high-quality, high-fidelity audio and electronic products for automotive, consumer and professional use. TPV Technology is a leading display solution provider, specializing in design and production of a wide spectrum of desktop monitors and LCD TVs. Textron Inc. is one of the world's best known multi-industry companies, consisting of numerous subsidiaries and operating units and known by familiar brand names, including Bell Helicopter, Cessna Aircraft, Greenlee and E-Z-GO, among others.

The MMP Portfolio patents cover techniques that enable higher performance and lower cost designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment and automobiles, which today have dozens of microprocessor-based features and benefits.

About the MMP Portfolio

The Moore Microprocessor Patent Portfolio contains intellectual property that is jointly owned by the privately-held TPL Group and publicly-held Patriot Scientific Corporation (OTCBB: PTSC.OB). The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio protects fundamental technology used in microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. Manufacturers of microprocessor-based products can learn more about how to participate in the MMP Portfolio Licensing Program by contacting: mmp-licensing@alliacense.com.

About Patriot Scientific

Headquartered in Carlsbad, California, Patriot Scientific Corporation provides data sharing and secure data solutions for a connected world. Patriot Scientific addresses the expanding market opportunities in the healthcare, justice and public safety industries through its wholly owned subsidiary Patriot Data Solutions Group, Inc. These growth activities are funded with revenues generated, in a large part, from the continuing successful Moore Microprocessor Patent(TM) Portfolio licensing partnership with The TPL Group. Patriot Scientific's integrated core intelligence solution addresses the critical data/information sharing needs of the healthcare industry, the Department of Homeland Security, the Department of Justice, and federal, state, and local public safety and law enforcement agencies. For more information on Patriot Scientific Corporation, visit: www.ptsc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.

    Contact:
    Angela Hartley
    Investor Relations
    ir@ptsc.com
    760-547-2700 ext. 102

SOURCE Patriot Scientific Corporation